Bernard F. Tobin
President bij Crescendo Bioscience LLC
Profiel
Bernard F.
Tobin currently works at Crescendo Bioscience LLC, as President.
Mr. Tobin also formerly worked at Amgen, Inc., as Executive Director-National Accounts, Eli Lilly & Co., as Principal, and Myriad Genetics, Inc., as President-Myriad Autoimmune.
Mr. Tobin received his undergraduate degree from Iowa State University and Masters Business Admin degree from The Fuqua School of Business.
Actieve functies van Bernard F. Tobin
| Bedrijven | Functie | Begin |
|---|---|---|
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | President | - |
Eerdere bekende functies van Bernard F. Tobin
| Bedrijven | Functie | Einde |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Opleiding van Bernard F. Tobin
| Iowa State University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| MYRIAD GENETICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
